Main Menu

We are attending AASLD The Liver Meeting® 2026 in Denver, CO

Learn More

AASLD 2026

The Liver Meeting®

Denver,CO | November 5-19, 2026

We are thrilled to return to this year’s The Liver Meeting at AASLD 2026 and connect with the global liver community once again.

Discover what we have planned for the conference below: 

SCIENTIFIC LINEUP

ORAL PRESENTATION

Late-breaker

Topline Histology Data: Zabopegdutide (DD01), a Dual GLP-1/Glucagon Agonist, Drives Significant Fibrosis Improvement and MASH Resolution at 48 Weeks

Presenter: Dr. Mazen Noureddin, MD

11/8/2026 at 2:45pm

POSTER PRESENTATIONS

qFibrosis-Based Collagen Microarchitecture Profiling Identifies Recurrence-Associated Fibrotic Signatures in HCC Biopsies

Presenter: Dr. Dean Tai, PhD

Publication number: 3370

Category: Liver Fibrogenesis and Non-Parenchymal Cell Biology (“3354-3403”)

11/7/2026, 1:00 pm – 2:00 pm

Multi-Omics Define Distinct Fibrogenic Remodeling Endotypes in Metabolic Dysfunction-Associated Steatohepatitis

Presenter: Dr. Zoltan Derdak, MD

Publication number: 2326

Category: Diagnostics and Biomarkers – MASH (“2294-2453”)

 11/6/2026, 1:00 pm – 2:00 pm

Automated AI-based Quantitative Fibrosis Staging to Support Identification of MASH Patients Eligible for Approved Therapies

Presenter: Dr. Yukti Choudhury, MD

Publication number: 2413

Category: Diagnostics and Biomarkers – MASH (“2294-2453”)

11/6/2026, 1:00 pm – 2:00 pm

HISTOINDEX EVENTS

Breakfast Meeting

November 5th (Thursday), 2026 | 7:00 - 8:30AM MST

Our signature scientific event, the HistoIndex Breakfast Meeting, returns for another year, bringing together leading experts for insightful discussion on “A Biopsy Fibrosis Feature-Based Model for Predicting Risk of Liver Decompensation in MASH” including two presentations:

  • From Biopsy to Prediction: Model Development & External Validation

  • Beyond F0–F4: Stratifying Risk Within Stages and Tracking Change Over Time

Breakfast Meeting Speakers & Panelists

Dr. Meena B. Bansal, MD, FAASLD SPEAKER
Professor of Medicine System Chief, Division of Liver Diseases Director, MASLD/MASH Center of Excellence at the Icahn School of Medicine at Mount Sinai
Dr. Mazen Noureddin, MD, MHSc,FAASLD SPEAKER
Professor of Medicine, Transplant Hepatologist at Houston Methodist Hospital and a Co-Chairman of the Board at Summit and Pinnacle Clinical Research
Dr. Naim Alkhouri, MD,FAASLD PANELIST
Chief Medical Officer at Summit Clinical Research and Director of the Clinical Research Institute of Ohio.
Dr. Roberto Calle, MD PANELIST
Vice President, Clinical Development Head - Hepatology at GSK
Dr. Becky Taub, MD PANELIST
Founder, Director and Senior Scientific and Medical Advisor at Madrigal Pharmaceuticals

EXHIBITION

Exhibition: Visit our Booth #𝟮𝟬𝟲𝟴

November 7-8th, 2026 | Colorado Convention Center | Denver,CO

Visit us throughout the TLM® exhibition to meet the HistoIndex team and discover what’s new.

We have some exciting developments to share and a whole new look for our booth! 

See you at the exhibition! 

Stay updated on our events

IMG_1012
General
Speakers_EASL_HistoIndex
AASLD_Poster 3
IMG_1008
Dr_Jonathan_Fallowfield_EASL_HistoIndexv
IMG_0992
IMG_1075
IMG_0898
IMG_3414
IMG_1312
Audience_EASL_HistoIndex
SH Presentation
#image_title
#image_title
QnA_EASL_HistoIndex
Panel_discusion_EASL_HistoIndex
Panelists_EASL_HistoIndex
Breakfast_Meeting_EASL_HistoIndex
#image_title